141 related articles for article (PubMed ID: 34970358)
1. Serum Levels of lncRNA CCHE1 and TCF21 in Patients with Coronary Artery Disease and Their Clinical Significances.
Liu M; Zhang Y; Cao X; Wang X
Dis Markers; 2021; 2021():8526144. PubMed ID: 34970358
[TBL] [Abstract][Full Text] [Related]
2. Circulating lncRNA IFNG-AS1 expression correlates with increased disease risk, higher disease severity and elevated inflammation in patients with coronary artery disease.
Xu Y; Shao B
J Clin Lab Anal; 2018 Sep; 32(7):e22452. PubMed ID: 29744951
[TBL] [Abstract][Full Text] [Related]
3. Expression level of lncRNA PVT1 in serum of patients with coronary atherosclerosis disease and its clinical significance.
Quan W; Hu PF; Zhao X; Lianhua CG; Batu BR
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6333-6337. PubMed ID: 32572930
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of lncRNA-AWPPH in coronary artery diseases.
Tang TT; Wang BQ
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11747-11751. PubMed ID: 33275243
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum cystatin-c and coronary lesion severity in coronary artery disease patients with a normal glomerular filtration rate.
Pan J; Sun X; Zhang P; Chen H; Lin J
J Int Med Res; 2021 Jan; 49(1):300060520985639. PubMed ID: 33435768
[TBL] [Abstract][Full Text] [Related]
6. Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells That Contribute to the Fibrous Cap.
Nurnberg ST; Cheng K; Raiesdana A; Kundu R; Miller CL; Kim JB; Arora K; Carcamo-Oribe I; Xiong Y; Tellakula N; Nanda V; Murthy N; Boisvert WA; Hedin U; Perisic L; Aldi S; Maegdefessel L; Pjanic M; Owens GK; Tallquist MD; Quertermous T
PLoS Genet; 2015 May; 11(5):e1005155. PubMed ID: 26020946
[TBL] [Abstract][Full Text] [Related]
7. [The association between serum adiponectin levels and the severity of coronary artery lesions on the angiogram].
Göksoy H; Dursunoğlu D; Oztürk M; Rota S
Turk Kardiyol Dern Ars; 2009 Jun; 37(4):241-5. PubMed ID: 19717956
[TBL] [Abstract][Full Text] [Related]
8. Characterization of TCF21 Downstream Target Regions Identifies a Transcriptional Network Linking Multiple Independent Coronary Artery Disease Loci.
Sazonova O; Zhao Y; Nürnberg S; Miller C; Pjanic M; Castano VG; Kim JB; Salfati EL; Kundaje AB; Bejerano G; Assimes T; Yang X; Quertermous T
PLoS Genet; 2015 May; 11(5):e1005202. PubMed ID: 26020271
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of circulating lncRNA ANRIL and its correlation with coronary artery disease parameters.
Hu Y; Hu J
Braz J Med Biol Res; 2019; 52(8):e8309. PubMed ID: 31411246
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Expression of Plasma lncRNA-HEIH and Prognosis in Patients with Coronary Artery Disease.
Zhang Z; Nan S; Duan X; Wang L; Sun X; Zheng H
Dis Markers; 2021; 2021():5662080. PubMed ID: 35003390
[TBL] [Abstract][Full Text] [Related]
11. Plasma Long Non-Coding RNA (lncRNA) GAS5 is a New Biomarker for Coronary Artery Disease.
Yin Q; Wu A; Liu M
Med Sci Monit; 2017 Dec; 23():6042-6048. PubMed ID: 29267258
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TARID induces cell proliferation through cell cycle pathway associated with coronary artery disease.
Cheng Z; Zhang Y; Zhuo Y; Fan J; Xu Y; Li M; Chen H; Zhou L
Mol Biol Rep; 2022 Jun; 49(6):4573-4581. PubMed ID: 35304681
[TBL] [Abstract][Full Text] [Related]
13. Association of serum C1q/TNF-related protein-3 (CTRP-3) in patients with coronary artery disease.
Wang S; Ling Y; Liang W; Shen L
BMC Cardiovasc Disord; 2017 Jul; 17(1):210. PubMed ID: 28754090
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of lipoprotein(a) with clinical stability and severity of coronary artery lesions in patients with coronary artery disease].
Ma Y; Rao J; Long J; Lin L; Liu J; Guo Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):235-240. PubMed ID: 30890514
[TBL] [Abstract][Full Text] [Related]
15. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease.
Yu J; Han J; Mao J; Guo L; Gao W
Chin Med J (Engl); 2014; 127(6):1039-45. PubMed ID: 24622431
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk.
Iyer D; Zhao Q; Wirka R; Naravane A; Nguyen T; Liu B; Nagao M; Cheng P; Miller CL; Kim JB; Pjanic M; Quertermous T
PLoS Genet; 2018 Oct; 14(10):e1007681. PubMed ID: 30307970
[TBL] [Abstract][Full Text] [Related]
17. High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes.
Samman Tahhan A; Sandesara P; Hayek SS; Hammadah M; Alkhoder A; Kelli HM; Topel M; O'Neal WT; Ghasemzadeh N; Ko YA; Gafeer MM; Abdelhadi N; Choudhary F; Patel K; Beshiri A; Murtagh G; Kim J; Wilson P; Shaw L; Vaccarino V; Epstein SE; Sperling L; Quyyumi AA
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29467150
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-Related Polymorphisms in miR-146a and TCF21 Are Associated with Increased Susceptibility to Coronary Artery Disease in an Iranian Population.
Bastami M; Ghaderian SM; Omrani MD; Mirfakhraie R; Vakili H; Parsa SA; Nariman-Saleh-Fam Z; Masotti A
Genet Test Mol Biomarkers; 2016 May; 20(5):241-8. PubMed ID: 26909569
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the serum alkaline phosphatase level and the severity of coronary artery disease.
Sahin I; Karabulut A; Gungor B; Avci II; Okuyan E; Kizkapan F; Yildiz SS; Can MM; Dinckal M
Coron Artery Dis; 2014 Jun; 25(4):349-52. PubMed ID: 24769515
[TBL] [Abstract][Full Text] [Related]
20. Relationship of serum Wnt1-inducible signaling pathway protein 1 levels with coronary artery disease and its severity.
Gu L; Chen N; Li Z; Zhang F; Wang X
Coron Artery Dis; 2019 Nov; 30(7):542-546. PubMed ID: 30998609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]